MiR-509-3p enhances platinum drug sensitivity in ovarian cancer
发布时间：2019-05-10 分享到：
… miRNA microarray system (Illumina) composed of probes targeting 2003 human miRNAs wasemployed to identify miRNA expression profile of platinum-sensitive and -resistant human ovariancancers by Biomiao (Biomiao, China) according to product protocol …
上一篇：Association of ENAM, TUFT1, MMP13, IL1B, IL10 and IL1RN gene polymorphism and dental caries susceptibility in Chinese children
下一篇：A functional copy-number variation in MAPKAPK2 predicts risk and prognosis of lung cancer
返回列表
相关推荐
- Increased osteogenesis in osteoporotic bone marrow stromal cells by ove2019-05-13
- Targeted P2X7R shRNA delivery attenuates sympathetic nerve sprouting an2019-05-13
- TNF-a (-238G/A and -308G/A) gene polymorphisms may not contribute to t2019-05-13
- Genetic polymorphisms in Sox17 associated with intracranial aneurysm in2019-05-13
- Association of ENAM, TUFT1, MMP13, IL1B, IL10 and IL1RN gene poly2019-05-13
- miR-509-3p enhances platinum drug sensitivity in ovarian cancer2019-05-13